Leo I Gordon Selected Research

Leo I Gordon Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 05/2002
45	Lymphoma (Lymphomas) 01/2022 - 04/2003
41	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2020 - 02/2002
18	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 06/2007
14	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2020 - 06/2004
13	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 07/2003
13	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2020 - 02/2008
13	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 06/2002
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2020 - 07/2003
7	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 07/2005
5	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2021 - 07/2008
5	Multiple Myeloma 05/2018 - 02/2002
4	Genetic Translocation (Chromosomal Translocation) 01/2017 - 09/2013
3	Burkitt Lymphoma (Burkitt's Lymphoma) 11/2020 - 07/2012
3	Thrombocytopenia (Thrombopenia) 10/2013 - 06/2002
2	Disease Progression 05/2022 - 01/2020
2	COVID-19 04/2022 - 11/2020
2	Cytokine Release Syndrome 01/2021 - 05/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2015
2	Starvation 02/2013 - 07/2003
2	Hypoxia (Hypoxemia) 01/2013 - 05/2008
2	Leukemia 01/2013 - 09/2012
2	Acute Promyelocytic Leukemia 09/2012 - 02/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2007 - 04/2003
2	Febrile Neutropenia 06/2007 - 07/2005
1	Critical Illness (Critically Ill) 04/2022

Drug/Important Bio-Agent (IBA)

25	Rituximab (Mabthera)FDA Link 10/2016 - 05/2002
20	ibritumomab tiuxetan (Zevalin)FDA Link 10/2009 - 02/2002
12	Proteins (Proteins, Gene)FDA Link 11/2021 - 07/2003
9	YttriumIBA 09/2007 - 02/2002
6	Pharmaceutical PreparationsIBA 01/2022 - 04/2003
6	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 02/2013
6	Monoclonal AntibodiesIBA 11/2021 - 07/2005
6	CholesterolIBA 01/2021 - 02/2013
6	HDL LipoproteinsIBA 01/2021 - 02/2013
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 06/2012
5	Vinblastine (Vinblastine Sulfate)FDA Link 01/2019 - 02/2013
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019 - 06/2007
5	Cyclin D1IBA 01/2017 - 08/2011
5	Biological ProductsIBA 01/2017 - 05/2002
5	Prednisone (Sone)FDA LinkGeneric 10/2016 - 04/2009
5	Vincristine (Oncovin)FDA LinkGeneric 10/2016 - 04/2009
5	Bortezomib (Velcade)FDA Link 08/2014 - 05/2009
4	Chimeric Antigen ReceptorsIBA 05/2022 - 05/2018
4	Arsenic Trioxide (Trisenox)FDA Link 01/2013 - 02/2002
4	motexafin gadoliniumIBA 04/2010 - 02/2005
4	Yttrium-90IBA 04/2009 - 04/2003
3	GoldIBA 01/2022 - 02/2013
3	Phosphotransferases (Kinase)IBA 11/2021 - 09/2012
3	high density lipoprotein receptorsIBA 01/2021 - 02/2013
3	Brentuximab VedotinIBA 01/2019 - 05/2014
3	Scavenger Receptors (Scavenger Receptor)IBA 01/2019 - 02/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2016 - 04/2009
3	Histone Deacetylase InhibitorsIBA 03/2016 - 05/2009
3	abexinostatIBA 03/2016 - 05/2009
3	Biomarkers (Surrogate Marker)IBA 01/2016 - 06/2006
3	DNA (Deoxyribonucleic Acid)IBA 05/2013 - 12/2012
3	CaspasesIBA 10/2010 - 05/2009
3	PorphyrinsIBA 10/2009 - 02/2005
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2009 - 02/2005
2	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2016
2	Immunoconjugates (Immunoconjugate)IBA 11/2021 - 08/2012
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 11/2017
2	ibrutinibIBA 11/2020 - 01/2017
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020 - 01/2013
2	GlucocorticoidsIBA 01/2020 - 01/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 01/2013
2	venetoclaxIBA 04/2018 - 12/2017
2	idelalisibIBA 04/2018 - 12/2017
2	Bevacizumab (Avastin)FDA Link 12/2015 - 06/2006
2	Etoposide (VP 16)FDA LinkGeneric 06/2015 - 04/2013
2	Mechlorethamine (Nitrogen Mustard)FDA Link 06/2015 - 04/2013
2	Nucleic AcidsIBA 01/2015 - 05/2013
2	pidilizumabIBA 09/2014 - 11/2013
2	ParaffinIBA 02/2013 - 10/2012
2	Formaldehyde (Formol)FDA Link 02/2013 - 10/2012
2	CurcuminIBA 08/2011 - 04/2011
2	Glutathione (Reduced Glutathione)IBA 08/2010 - 07/2005
1	Hemoglobins (Hemoglobin)IBA 04/2022
1	axicabtagene ciloleucelIBA 01/2022
1	AnthracyclinesIBA 01/2022
1	cytidylyl-3'-5'-guanosineIBA 01/2022
1	pembrolizumabIBA 11/2021
1	Immunoglobulin G (IgG)IBA 11/2021
1	IronIBA 01/2021

Therapy/Procedure

51	Therapeutics 05/2022 - 06/2002
23	Drug Therapy (Chemotherapy) 05/2022 - 06/2002
16	Radioimmunotherapy 01/2018 - 02/2002
7	Stem Cell Transplantation 01/2022 - 10/2013
4	Radiotherapy 01/2022 - 02/2013
4	Aftercare (After-Treatment) 05/2009 - 04/2003
3	Immunotherapy 12/2021 - 05/2002
2	Transplantation 01/2022 - 11/2010
2	Precision Medicine 01/2019 - 01/2013
2	Lymphatic Irradiation 01/2019 - 06/2014
2	Treatment Delay 01/2018 - 10/2013
2	Induction Chemotherapy 10/2016 - 07/2010
2	Combination Drug Therapy (Combination Chemotherapy) 06/2015 - 11/2013
2	Hematopoietic Stem Cell Transplantation 11/2013 - 04/2010
1	Photothermal Therapy 01/2022